Fuck you @plannedparenthood The world of economics runs on the basis of supply and demand. And this is perhaps the largest fear to approving fetal tissue research and transplants from elective aborted fetuses. While it is claimed that supply is sufficient to meet current demand – which is a tragedy in itself – what is to happen when researchers discover that the fetal tissue products can effectively treat a broader assortment of disease and illnesses? What happens when there is still not enough supply? While these questions may seem overstated, we should not underestimate the advances of medical technology or the moral corruption of modern society. Several proposals were brought to the National Institutes of Health Panel to protect babies from being procured for the motive of profit. Yet with an estimated annual income of six billion dollars, the potential for abuse in fetal tissue industry would be substantial, not to mention very difficult to regulate and enforce. ‘With the anticipated profitability of the industry once the technology can alleviate a larger number of diseases, there will be increasing pressures to “share the wealth” produced by these transplants.’ (Scott Rae, ibid) Related to the supply of the fetus, is the supply of fresh and more mature fetuses. The timing of abortion becomes an important consideration to the researchers and medical community who benefit from a more matured and developed fetus. The majority of abortions procedures are performed between the sixth and eleventh weeks of pregnancy, however delaying until the fourteen to sixteenth weeks will yield fetal tissue that is usable in pancreatic transplants. Simply put, the older the fetus the more valuable! A subsequent concern of delaying the abortion procedures until the ‘ripe’ time period, is the emotional effects this will have for the mother. Aborting the unborn baby at four months old (as opposed to 6-11 weeks old) will compound the emotional impact on the mother resulting in a significant increase in post abortion trauma